CoChat

Mycoplasma pneumoniae infections–does treatment help?

Spuesens, Emiel B.M., Meyer Sauteur, Patrick M., Vink, Cornelis, van Rossum, Annemarie M.C. · 2014 · Journal of Infection
Cited by 47

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jinf.2014.07.017

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 44

  1. Michelow, 2004, Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children, Pediatrics, 113, 701, 10.1542/peds.113.4.701 · DOI · Paper page
  2. Himmelreich, 1996, Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae, Nucleic Acids Res, 24, 4420, 10.1093/nar/24.22.4420 · DOI · Paper page
  3. Ruland, 1994, Sequence divergence in the ORF6 gene of Mycoplasma pneumonia, J Bacteriol, 176, 5202, 10.1128/jb.176.17.5202-5209.1994 · DOI
  4. Krause, 2001, Structure, function, and assembly of the terminal organelle of Mycoplasma pneumoniae, FEMS Microbiol Lett, 198, 1, 10.1111/j.1574-6968.2001.tb10610.x · DOI
  5. Rottem, 2000, Mycoplasma interaction with eukaryotic cells, Subcell Biochem, 33, 199, 10.1007/978-1-4757-4580-1_9 · DOI
  6. Balish, 2003, Deletion analysis identifies key functional domains of the cytadherence-associated protein HMW2 of Mycoplasma pneumoniae, Mol Microbiol, 50, 1507, 10.1046/j.1365-2958.2003.03807.x · doi:10.1046/j.1365-2958.2003.03807.x
  7. Waldo, 2005, Identification and complementation of a mutation associated with loss of Mycoplasma pneumoniae virulence-specific proteins B and C, J Bacteriol, 187, 747, 10.1128/JB.187.2.747-751.2005 · doi:10.1128/jb.187.2.747-751.2005
  8. Atkinson, 2008, Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections, FEMS Microbiol Rev, 32, 956, 10.1111/j.1574-6976.2008.00129.x · DOI · Paper page
  9. Wang, 2012, Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia, Cochrane Database Syst Rev, 10, CD009175
  10. Bradley, 2011, The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, Clin Infect Dis, 53, e25, 10.1093/cid/cir531 · DOI · Paper page
  11. Harris, 2011, British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011, Thorax, 66, ii1
  12. Spuesens, 2013, Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study, PLoS Med, 10, e1001444, 10.1371/journal.pmed.1001444 · DOI · Paper page
  13. Atkinson, 2014, Mycoplasma pneumoniae infections in childhood, Pediatr Infect Dis J, 33, 92, 10.1097/INF.0000000000000171 · doi:10.1097/inf.0000000000000171
  14. Adefurin, 2011, Ciprofloxacin safety in paediatrics: a systematic review, Arch Dis Child, 96, 874, 10.1136/adc.2010.208843 · doi:10.1136/adc.2010.208843
  15. Bebear, 2011, Mycoplasma pneumoniae: susceptibility and resistance to antibiotics, Future Microbiol, 6, 423, 10.2217/fmb.11.18 · DOI · Paper page
  16. Mulholland, 2012, Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children, Cochrane Database Syst Rev, 12, CD004875
  17. Matsuda, 2013, Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan, BMC Infect Dis, 13, 591, 10.1186/1471-2334-13-591 · doi:10.1186/1471-2334-13-591
  18. Kawai, 2013, Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients, Antimicrobial Agents Chemother, 57, 4046, 10.1128/AAC.00663-13 · DOI
  19. Qu, 2013, Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility, PLoS One, 8, e82174, 10.1371/journal.pone.0082174 · DOI
  20. Ma, 2014, Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen China, Pediatr Pulmonol, 49, 695, 10.1002/ppul.22851 · DOI
  21. Zhao, 2013, Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012, Antimicrobial Agents Chemother, 57, 1521, 10.1128/AAC.02060-12 · DOI
  22. Wu, 2013, Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan, Pediatr Pulmonol, 48, 904, 10.1002/ppul.22706 · DOI
  23. Uh, 2013, Macrolide resistance of Mycoplasma pneumoniae and its detection rate by real-time PCR in primary and tertiary care hospitals, Ann Lab Med, 33, 410, 10.3343/alm.2013.33.6.410 · DOI
  24. Hong, 2013, Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000–2011, Emerg Infect Dis, 19, 1281, 10.3201/eid1908.121455 · doi:10.3201/eid1908.121455
  25. Eshaghi, 2013, Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010–2011, Emerg Infect Dis, 19, 1525, 10.3201/eid1909.121466 · doi:10.3201/eid1909.121466
  26. Dumke, 2013, Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012, Antimicrobial Agents Chemother, 57, 3460, 10.1128/AAC.00706-13 · doi:10.1128/aac.00706-13
  27. Pereyre, 2013, The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains, Clin Microbiol Infect, 19, E212, 10.1111/1469-0691.12107 · doi:10.1111/1469-0691.12107
  28. Ferguson, 2013, Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK, J Med Microbiol, 62, 1876, 10.1099/jmm.0.066191-0 · DOI
  29. Okazaki, 2001, Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro, Microbiol Immunol, 45, 617, 10.1111/j.1348-0421.2001.tb01293.x · DOI · Paper page
  30. Pereyre, 2004, In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae, Antimicrobial Agents Chemother, 48, 460, 10.1128/AAC.48.2.460-465.2004 · DOI
  31. Lucier, 1995, Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae, Antimicrobial Agents Chemother, 39, 2770, 10.1128/AAC.39.12.2770 · DOI · Paper page
  32. Averbuch, 2011, Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010, Emerg Infect Dis, 17, 1079, 10.3201/eid1706.101558 · doi:10.3201/eid1706.101558
  33. Hantz, 2012, Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child, J Clin Microbiol, 50, 3402, 10.1128/JCM.01248-12 · DOI
  34. Chironna, 2011, Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children, J Antimicrob Chemother, 66, 734, 10.1093/jac/dkr003 · DOI
  35. Liu, 2012, Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis, J Clin Microbiol, 50, 2793, 10.1128/JCM.00678-12 · DOI
  36. Morozumi, 2010, Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia, J Infect Chemother, 16, 78, 10.1007/s10156-009-0021-4 · DOI · Paper page
  37. Li, 2009, Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates, Pediatr Infect Dis J, 28, 693, 10.1097/INF.0b013e31819e3f7a · DOI
  38. Morozumi, 2008, Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia, Antimicrobial Agents Chemother, 52, 348, 10.1128/AAC.00779-07 · DOI · Paper page
  39. Suzuki, 2006, Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae, Antimicrobial Agents Chemother, 50, 709, 10.1128/AAC.50.2.709-712.2006 · DOI · Paper page
  40. Matsubara, 2009, A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients, J Infect Chemother, 15, 380, 10.1007/s10156-009-0715-7 · doi:10.1007/s10156-009-0715-7
  41. Kawai, 2013, Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients, Antimicrobial Agents Chemother, 57, 2252, 10.1128/AAC.00048-13 · doi:10.1128/aac.00048-13
  42. Okada, 2012, Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children, Clin Infect Dis, 55, 1642, 10.1093/cid/cis784 · DOI · Paper page
  43. Matsuoka, 2004, Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan, Antimicrobial Agents Chemother, 48, 4624, 10.1128/AAC.48.12.4624-4630.2004 · DOI · Paper page
  44. Labro, 1998, Anti-inflammatory activity of macrolides: a new therapeutic potential?, J Antimicrobial Chemother, 37, 10.1093/jac/41.suppl_2.37 · DOI · Paper page

Cited by

See all 47

Metadata

Authors
Spuesens, E. B. M., Meyer Sauteur, P. M., Vink, C., & van Rossum, A. M. C.
Venue
Journal of Infection
Publisher
Elsevier BV
Published
2014-11
Volume
69
Pages
S42-S46
ISSN
0163-4453
Cited by
47
References
3
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Swiss National Science Foundation (PBZHP3_147290)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mycoplasma pneumoniae infections–does treatment help? https://app.cochat.ai/papers/10.1016/j.jinf.2014.07.017
The paper
Spuesens, E. B. M., Meyer Sauteur, P. M., Vink, C., & van Rossum, A. M. C. (2014). Mycoplasma pneumoniae infections–does treatment help? Journal of Infection. https://doi.org/10.1016/j.jinf.2014.07.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.